Table 1.
Advantages | Drawbacks | |
---|---|---|
Xenografts | • Human diseases • Ready to use | • Engraftment difficulties • Experimental reproducibility • Transplantability? • Cohorts size and homogeneity |
Viral transformation‐derived models | • Fast • Allow large‐scale experiments | • Choice of oncogene(s) • Insertion site issues |
Transgenics‐derived models | • Reproducible • Allow large‐scale experiments | • Choice of transgene(s) • Choice of promoter/cell type specificity issue • Time‐consuming |